|
|
|
|
Дата |
|---|
| 24.08.2025 |
| 21.08.2025 |
| 20.08.2025 |
| 19.08.2025 |
| 18.08.2025 |
| 17.08.2025 |
| 14.08.2025 |
| 13.08.2025 |
| 12.08.2025 |
| 11.08.2025 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
53.62
|
53.63
|
54.80
|
53.86
|
|
|
18 852 082.55
|
444.00
|
|
|
|
54.00
|
53.30
|
54.60
|
53.62
|
|
|
16 766 438.14
|
434.00
|
|
|
|
55.73
|
54.00
|
55.90
|
54.00
|
|
|
23 641 535.43
|
482.00
|
|
|
|
55.59
|
55.67
|
56.50
|
55.73
|
|
|
23 035 229.91
|
712.00
|
|
|
|
53.54
|
53.70
|
56.39
|
55.59
|
|
|
105 515 055.52
|
1 467.00
|
|
|
|
52.30
|
43.60
|
53.68
|
53.54
|
|
|
7 282 659.64
|
385.00
|
|
|
|
52.03
|
51.61
|
52.69
|
52.30
|
|
|
3 189 130.28
|
175.00
|
|
|
|
52.24
|
51.93
|
52.50
|
52.03
|
|
|
2 262 001.91
|
160.00
|
|
|
|
52.20
|
51.77
|
52.70
|
52.24
|
|
|
16 079 812.93
|
141.00
|
|
|
|
52.80
|
51.76
|
52.95
|
52.20
|
|
|
3 689 098.59
|
259.00
|
Период |
|---|
| 2022, регулярные |
| 2020, регулярные |
| 2018, регулярные |
| 2017, регулярные |
| 2016, регулярные |
| 2015, регулярные |
| 2012, регулярные |
| 2011, регулярные |
| 2010, регулярные |
|
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
|---|---|---|
|
13.04.2023
|
18.04.2023 |
2 EGP |
|
21.04.2021
|
25.04.2021 |
2.95 EGP |
|
02.05.2019
|
05.05.2019 |
4 EGP |
|
06.04.2018
|
10.04.2018 |
4.5 EGP |
|
08.05.2017
|
09.05.2017 |
3.5 EGP |
|
21.04.2016
|
24.04.2016 |
3.5 EGP |
|
23.04.2013
|
24.04.2013 |
3 EGP |
|
24.05.2012
|
27.05.2012 |
3 EGP |
|
29.04.2011
|
02.05.2011 |
2.5 EGP |
Egyptian International Pharmaceuticals Industries Co SAE (EIPICO) is an Egypt-based public shareholding company that operates in the pharmaceuticals industry. The Company is a manufacturer and exporter of pharmaceuticals, and holds license agreements with a group of international pharmaceutical companies to produce their products locally and replace the imported ones. The Company produces dosage forms, such as spansule capsules (long-acting), as well as non-traditional dosage forms, such as the soft gelatin capsules, lyophilized products, gels, sprayers and effervescent tablets
